Log in to save to my catalogue

CYP3A subfamily activity affects the equilibrium concentration of Phenazepam ® in patients with anxi...

CYP3A subfamily activity affects the equilibrium concentration of Phenazepam ® in patients with anxi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_2217_pgs_2019_0071

CYP3A subfamily activity affects the equilibrium concentration of Phenazepam ® in patients with anxiety disorders and comorbid alcohol use disorder

About this item

Full title

CYP3A subfamily activity affects the equilibrium concentration of Phenazepam ® in patients with anxiety disorders and comorbid alcohol use disorder

Publisher

England

Journal title

Pharmacogenomics, 2020-05, Vol.21 (7), p.449-457

Language

English

Formats

Publication information

Publisher

England

More information

Scope and Contents

Contents

Phenazepam
is prescribed to relieve anxiety and sleep disorders during alcohol withdrawal, although it is associated with undesirable side effects.
To demonstrate changes in the safety and efficacy profiles of Phenazepam in patients with anxiety disorders and comorbid alcohol use disorder.
A total of 94 Russian patients with alcohol use di...

Alternative Titles

Full title

CYP3A subfamily activity affects the equilibrium concentration of Phenazepam ® in patients with anxiety disorders and comorbid alcohol use disorder

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_2217_pgs_2019_0071

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_2217_pgs_2019_0071

Other Identifiers

ISSN

1462-2416

E-ISSN

1744-8042

DOI

10.2217/pgs-2019-0071

How to access this item